Rajeka相关文献与解析，生知库 | 链接生命科学的每一步

Exploring the experiences and perceptions of co-administration of routine vaccines in adults: Findings from an embedded qualitative study with participants and research delivery staff in the ZosterFluCov randomized controlled trial

探索成人常规疫苗联合接种的经验和看法：一项针对带状疱疹疫苗和流感疫苗随机对照试验参与者及研究人员的嵌入式定性研究结果

期刊:Human Vaccines & Immunotherapeutics

影响因子:

doi:10.1080/21645515.2026.2629670

Williams, Victoria; Rees, Sophie; Seale, Holly; Tilzey, Grace; Lazarus, Rajeka

Working under short timescales to deliver a national trial: a case study of the ComFluCOV trial from a statistician's perspective

在时间紧迫的情况下开展全国性试验：从统计学家的角度对ComFluCOV试验进行案例研究

期刊:Trials

影响因子:2

doi:10.1186/s13063-023-07879-9

Harris, Rosie; Thirard, Russell; Baos, Sarah; Lazarus, Rajeka; Todd, Rachel; Kirwan, Jana; Joyce, Katherine; Hutton, David; Clout, Maddie; Cappel-Porter, Heike; Culliford, Lucy; Rogers, Chris A

发表日期：2024

文献求助收藏

Delivering COVID-19 vaccine trials at speed: the implementation of a phase IV UK multi-centre randomised controlled trial to determine safety and immunogenicity of COVID-19 vaccines co-administered with seasonal influenza vaccines (ComFluCOV)

快速开展 COVID-19 疫苗试验：实施英国 IV 期多中心随机对照试验，以确定 COVID-19 疫苗与季节性流感疫苗联合接种的安全性和免疫原性 (ComFluCOV)

期刊:Trials

影响因子:2

doi:10.1186/s13063-023-07862-4

Baos, Sarah; Todd, Rachel; Thirard, Russell; Harris, Rosie; Kirwan, Jana; Joyce, Katherine; Hutton, David; Finn, Adam; Clout, Madeleine; Cappel-Porter, Heike; Rogers, Chris A; Lazarus, Rajeka; Culliford, Lucy

Improving influenza vaccine uptake in clinical risk groups: patient, provider and commissioner perspectives on the acceptability and feasibility of expanding delivery pathways in England

提高临床高危人群流感疫苗接种率：患者、医疗服务提供者和委托机构对扩大英格兰疫苗接种途径的可接受性和可行性的看法

期刊:

影响因子:

doi:10.1136/bmjph-2024-000929

Kasstan, Ben; Lazarus, Rajeka; Ali, Ifra; Mounier-Jack, Sandra

Prolonged T-cell activation and long COVID symptoms independently associate with severe COVID-19 at 3 months

T细胞活化持续时间延长和新冠长期症状与3个月后出现重症新冠独立相关。

期刊:Elife

影响因子:6.4

doi:10.7554/eLife.85009

Marianna Santopaolo # ，Michaela Gregorova # ，Fergus Hamilton ，David Arnold ，Anna Long ，Aurora Lacey ，Elizabeth Oliver ，Alice Halliday ，Holly Baum ，Kristy Hamilton ，Rachel Milligan ，Olivia Pearce ，Lea Knezevic ，Begonia Morales Aza ，Alice Milne ，Emily Milodowski ，Eben Jones ，Rajeka Lazarus ，Anu Goenka ，Adam Finn ，Nicholas Maskell ，Andrew D Davidson ，Kathleen Gillespie ，Linda Wooldridge ，Laura Rivino

Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial

在英国开展的一项单盲、随机、II期非劣效性试验（Com-COV2），旨在评估包含mRNA疫苗、病毒载体疫苗和蛋白佐剂疫苗的异源性COVID-19初次免疫接种的免疫原性、安全性和反应原性。

期刊:Lancet

影响因子:88.5

doi:10.1016/S0140-6736(21)02718-5

Stuart, Arabella S V; Shaw, Robert H; Liu, Xinxue; Greenland, Melanie; Aley, Parvinder K; Andrews, Nick J; Cameron, J C; Charlton, Sue; Clutterbuck, Elizabeth A; Collins, Andrea M; Darton, Tom; Dinesh, Tanya; Duncan, Christopher J A; England, Anna; Faust, Saul N; Ferreira, Daniela M; Finn, Adam; Goodman, Anna L; Green, Christopher A; Hallis, Bassam; Heath, Paul T; Hill, Helen; Horsington, Bryn M; Lambe, Teresa; Lazarus, Rajeka; Libri, Vincenzo; Lillie, Patrick J; Mujadidi, Yama F; Payne, Ruth; Plested, Emma L; Provstgaard-Morys, Samuel; Ramasamy, Maheshi N; Ramsay, Mary; Read, Robert C; Robinson, Hannah; Screaton, Gavin R; Singh, Nisha; Turner, David P J; Turner, Paul J; Vichos, Iason; White, Rachel; Nguyen-Van-Tam, Jonathan S; Snape, Matthew D

Safety and immunogenicity of the inactivated whole-virus adjuvanted COVID-19 vaccine VLA2001: A randomized, dose escalation, double-blind phase 1/2 clinical trial in healthy adults

灭活全病毒佐剂新冠疫苗VLA2001的安全性和免疫原性：一项在健康成人中开展的随机、剂量递增、双盲1/2期临床试验

期刊:Journal of Infection

影响因子:11.9

doi:10.1016/j.jinf.2022.06.009

Lazarus, Rajeka; Taucher, Christian; Brown, Claire; Čorbic Ramljak, Irena; Danon, Leon; Dubischar, Katrin; Duncan, Christopher J A; Eder-Lingelbach, Susanne; Faust, Saul N; Green, Christopher; Gokani, Karishma; Hochreiter, Romana; Wright, Johanna Kellett; Kwon, Dowan; Middleditch, Alexander; Munro, Alasdair P S; Naker, Kush; Penciu, Florentina; Price, David; Querton, Benedicte; Riaz, Tawassal; Ross-Russell, Amy; Sanchez-Gonzalez, Amada; Wardle, Hayley; Warren, Sarah; Finn, Adam

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial

腺病毒载体和mRNA COVID-19疫苗（Com-COV）异源与同源初免-加强免疫方案的安全性和免疫原性：一项单盲、随机、非劣效性试验

期刊:Lancet

影响因子:88.5

doi:10.1016/S0140-6736(21)01694-9

Liu, Xinxue; Shaw, Robert H; Stuart, Arabella S V; Greenland, Melanie; Aley, Parvinder K; Andrews, Nick J; Cameron, J Claire; Charlton, Sue; Clutterbuck, Elizabeth A; Collins, Andrea M; Dinesh, Tanya; England, Anna; Faust, Saul N; Ferreira, Daniela M; Finn, Adam; Green, Christopher A; Hallis, Bassam; Heath, Paul T; Hill, Helen; Lambe, Teresa; Lazarus, Rajeka; Libri, Vincenzo; Long, Fei; Mujadidi, Yama F; Plested, Emma L; Provstgaard-Morys, Samuel; Ramasamy, Maheshi N; Ramsay, Mary; Read, Robert C; Robinson, Hannah; Singh, Nisha; Turner, David P J; Turner, Paul J; Walker, Laura L; White, Rachel; Nguyen-Van-Tam, Jonathan S; Snape, Matthew D

Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial

英国成人同时接种 COVID-19 疫苗（ChAdOx1 或 BNT162b2）和季节性流感疫苗的安全性和免疫原性（ComFluCOV）：一项多中心、随机、对照的 4 期试验

期刊:Lancet

影响因子:88.5

doi:10.1016/S0140-6736(21)02329-1

Lazarus, Rajeka; Baos, Sarah; Cappel-Porter, Heike; Carson-Stevens, Andrew; Clout, Madeleine; Culliford, Lucy; Emmett, Stevan R; Garstang, Jonathan; Gbadamoshi, Lukuman; Hallis, Bassam; Harris, Rosie A; Hutton, David; Jacobsen, Nick; Joyce, Katherine; Kaminski, Rachel; Libri, Vincenzo; Middleditch, Alex; McCullagh, Liz; Moran, Ed; Phillipson, Adrian; Price, Elizabeth; Ryan, John; Thirard, Russell; Todd, Rachel; Snape, Matthew D; Tucker, David; Williams, Rachel Lauren; Nguyen-Van-Tam, Jonathan S; Finn, Adam; Rogers, Chris A

Attitudes to vaccine co-administration in adults: A scoping review of qualitative evidence

成人疫苗联合接种态度：一项定性证据范围综述

Exploring the experiences and perceptions of co-administration of routine vaccines in adults: Findings from an embedded qualitative study with participants and research delivery staff in the ZosterFluCov randomized controlled trial

探索成人常规疫苗联合接种的经验和看法：一项针对带状疱疹疫苗和流感疫苗随机对照试验参与者及研究人员的嵌入式定性研究结果

Working under short timescales to deliver a national trial: a case study of the ComFluCOV trial from a statistician's perspective

在时间紧迫的情况下开展全国性试验：从统计学家的角度对ComFluCOV试验进行案例研究

Delivering COVID-19 vaccine trials at speed: the implementation of a phase IV UK multi-centre randomised controlled trial to determine safety and immunogenicity of COVID-19 vaccines co-administered with seasonal influenza vaccines (ComFluCOV)

快速开展 COVID-19 疫苗试验：实施英国 IV 期多中心随机对照试验，以确定 COVID-19 疫苗与季节性流感疫苗联合接种的安全性和免疫原性 (ComFluCOV)

Improving influenza vaccine uptake in clinical risk groups: patient, provider and commissioner perspectives on the acceptability and feasibility of expanding delivery pathways in England

提高临床高危人群流感疫苗接种率：患者、医疗服务提供者和委托机构对扩大英格兰疫苗接种途径的可接受性和可行性的看法

Prolonged T-cell activation and long COVID symptoms independently associate with severe COVID-19 at 3 months

T细胞活化持续时间延长和新冠长期症状与3个月后出现重症新冠独立相关。

Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial

在英国开展的一项单盲、随机、II期非劣效性试验（Com-COV2），旨在评估包含mRNA疫苗、病毒载体疫苗和蛋白佐剂疫苗的异源性COVID-19初次免疫接种的免疫原性、安全性和反应原性。

Safety and immunogenicity of the inactivated whole-virus adjuvanted COVID-19 vaccine VLA2001: A randomized, dose escalation, double-blind phase 1/2 clinical trial in healthy adults

灭活全病毒佐剂新冠疫苗VLA2001的安全性和免疫原性：一项在健康成人中开展的随机、剂量递增、双盲1/2期临床试验

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial

腺病毒载体和mRNA COVID-19疫苗（Com-COV）异源与同源初免-加强免疫方案的安全性和免疫原性：一项单盲、随机、非劣效性试验

Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial

英国成人同时接种 COVID-19 疫苗（ChAdOx1 或 BNT162b2）和季节性流感疫苗的安全性和免疫原性（ComFluCOV）：一项多中心、随机、对照的 4 期试验